Tokyo Tape
Sign in
← Chiome Bioscience

Quarterly report · Q3

4583.TEDINET S100S992
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥524m2023-01-01 → 2023-09-30StandaloneNet sales
Revenue¥631m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥434m2022-01-01 → 2022-09-30StandaloneNet sales
Operating income−¥905m2023-01-01 → 2023-09-30StandaloneOperating income
Operating income−¥1.0bn2022-01-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥916m2023-01-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.0bn2022-01-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥915m2023-01-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥1.0bn2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥918m2023-01-01 → 2023-09-30StandaloneProfit loss
Net income−¥1.2bn2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥1.0bn2022-01-01 → 2022-09-30StandaloneProfit loss
Total assets¥1.8bnat 2023-09-30StandaloneAssets
Total assets¥2.2bnat 2022-12-31StandaloneAssets
Total assets¥2.1bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥542mat 2023-09-30StandaloneLiabilities
Total liabilities¥425mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-18.822023-01-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.152023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.262022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-23.872022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.82022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio67.8%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued50,571,400at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued48,423,500at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued45,979,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥409m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-09-30−¥803m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-09-30¥524m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-09-30¥524m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-09-30¥307m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-09-30¥524m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-09-30¥524m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-09-30−¥496m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥358m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-09-30−¥916m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-09-30¥434m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-09-30¥434m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-09-30¥235m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-09-30¥434m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-09-30¥434m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-09-30−¥681m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 329
ItemContextValueUnit
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember6100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember48487600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember484876
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember10100
Number of shares issued shares voting rightsCurrentQuarterInstant48503800
Number of voting rights issued shares voting rightsCurrentQuarterInstant484876
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member6100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member6100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.000
Number of shares held in own name treasury shares etcCurrentQuarterInstant6100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant6100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.000
Cash and depositsPrior1YearInstant_NonConsolidatedMember1727270000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember1341811000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember115218000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember84280000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember71478000JPY
InventoriesCurrentQuarterInstant_NonConsolidatedMember58089000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember91477000JPY
Advance payments tradeCurrentQuarterInstant_NonConsolidatedMember83948000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember29567000JPY
Consumption taxes receivableCurrentQuarterInstant_NonConsolidatedMember12483000JPY
Other caPrior1YearInstant_NonConsolidatedMember57154000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember53146000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember2092166000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember1633759000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember254610000JPY
Machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember234713000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-252173000JPY
Accumulated depreciation machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember-233253000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember2437000JPY
Machinery and equipment netCurrentQuarterInstant_NonConsolidatedMember1459000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember97024000JPY
Tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember90671000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-97024000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember-90671000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netCurrentQuarterInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember2437000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember1459000JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember8055000JPY
Long term prepaid expensesCurrentQuarterInstant_NonConsolidatedMember5172000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember112811000JPY
Lease and guarantee depositsCurrentQuarterInstant_NonConsolidatedMember112811000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember120866000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass